Last reviewed · How we verify
GSK1265744 Free Acid Micronized Capsules
GSK1265744 Free Acid Micronized Capsules is a Small molecule drug developed by ViiV Healthcare. It is currently in Phase 1 development.
At a glance
| Generic name | GSK1265744 Free Acid Micronized Capsules |
|---|---|
| Sponsor | ViiV Healthcare |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- GSK1265744 Free Acid Micronized Capsules CI brief — competitive landscape report
- GSK1265744 Free Acid Micronized Capsules updates RSS · CI watch RSS
- ViiV Healthcare portfolio CI
Frequently asked questions about GSK1265744 Free Acid Micronized Capsules
What is GSK1265744 Free Acid Micronized Capsules?
GSK1265744 Free Acid Micronized Capsules is a Small molecule drug developed by ViiV Healthcare.
Who makes GSK1265744 Free Acid Micronized Capsules?
GSK1265744 Free Acid Micronized Capsules is developed by ViiV Healthcare (see full ViiV Healthcare pipeline at /company/viiv-healthcare).
What development phase is GSK1265744 Free Acid Micronized Capsules in?
GSK1265744 Free Acid Micronized Capsules is in Phase 1.